ADR,SEQ,PT,HLT,HLGT,SOC_ABBREV,FATAL_YN
1,1,Macular hole,"Retinal structural change, deposit and degeneration","Ocular structural change, deposit and degeneration NEC",Eye,N
2,1,Retinal detachment,"Retinal structural change, deposit and degeneration","Ocular structural change, deposit and degeneration NEC",Eye,N
3,1,Retinal detachment,"Retinal structural change, deposit and degeneration","Ocular structural change, deposit and degeneration NEC",Eye,N
4,1,Macular hole,"Retinal structural change, deposit and degeneration","Ocular structural change, deposit and degeneration NEC",Eye,N
5,1,Disease progression,General signs and symptoms NEC,General system disorders NEC,Genrl,N
5,2,Macular hole,"Retinal structural change, deposit and degeneration","Ocular structural change, deposit and degeneration NEC",Eye,N
5,3,Visual acuity reduced,Visual impairment and blindness (excl colour blindness),Vision disorders,Eye,N
6,1,Blindness transient,Visual impairment and blindness (excl colour blindness),Vision disorders,Eye,N
6,2,Dyschromatopsia,Colour blindness (incl acquired),Vision disorders,Eye,N
6,3,Metamorphopsia,Visual disorders NEC,Vision disorders,Eye,N
6,4,Night blindness,Visual impairment and blindness (excl colour blindness),Vision disorders,Eye,N
6,5,Photopsia,Visual disorders NEC,Vision disorders,Eye,N
6,6,Retinal fovea disorder,Ocular disorders NEC,Eye disorders NEC,Eye,N
6,7,Retinal vascular disorder,Retinal bleeding and vascular disorders (excl retinopathy),"Retina, choroid and vitreous haemorrhages and vascular disorders",Eye,N
6,8,Vision blurred,Visual disorders NEC,Vision disorders,Eye,N
6,9,Visual impairment,Visual impairment and blindness (excl colour blindness),Vision disorders,Eye,N
7,1,Disease progression,General signs and symptoms NEC,General system disorders NEC,Genrl,N
7,2,Dyschromatopsia,Colour blindness (incl acquired),Vision disorders,Eye,N
7,3,Macular hole,"Retinal structural change, deposit and degeneration","Ocular structural change, deposit and degeneration NEC",Eye,N
7,4,Photopsia,Visual disorders NEC,Vision disorders,Eye,N
7,5,Pupillary reflex impaired,Pupil disorders,Ocular neuromuscular disorders,Eye,N
7,6,Visual acuity reduced,Visual impairment and blindness (excl colour blindness),Vision disorders,Eye,N
7,7,Visual impairment,Visual impairment and blindness (excl colour blindness),Vision disorders,Eye,N
7,8,Visual impairment,Visual impairment and blindness (excl colour blindness),Vision disorders,Eye,N
8,1,Intraocular pressure increased,Ophthalmic function diagnostic procedures,"Neurological, special senses and psychiatric investigations",Inv,N
9,1,Retinal tear,"Retinal structural change, deposit and degeneration","Ocular structural change, deposit and degeneration NEC",Eye,N
10,1,Macular hole,"Retinal structural change, deposit and degeneration","Ocular structural change, deposit and degeneration NEC",Eye,N
11,1,Disease progression,General signs and symptoms NEC,General system disorders NEC,Genrl,N
11,2,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
11,3,Pupillary reflex impaired,Pupil disorders,Ocular neuromuscular disorders,Eye,N
11,4,Retinal cyst,"Retinal structural change, deposit and degeneration","Ocular structural change, deposit and degeneration NEC",Eye,N
11,5,Retinal degeneration,"Retinal structural change, deposit and degeneration","Ocular structural change, deposit and degeneration NEC",Eye,N
11,6,Visual acuity reduced transiently,Visual impairment and blindness (excl colour blindness),Vision disorders,Eye,N
11,7,Visual impairment,Visual impairment and blindness (excl colour blindness),Vision disorders,Eye,N
12,1,Blindness transient,Visual impairment and blindness (excl colour blindness),Vision disorders,Eye,N
12,2,Vision blurred,Visual disorders NEC,Vision disorders,Eye,N
12,3,Visual impairment,Visual impairment and blindness (excl colour blindness),Vision disorders,Eye,N
12,4,Vitreous floaters,"Choroid and vitreous structural change, deposit and degeneration","Ocular structural change, deposit and degeneration NEC",Eye,N
13,1,Retinal injury,Eye injuries NEC,Injuries NEC,Inj&P,N
14,1,Dyschromatopsia,Colour blindness (incl acquired),Vision disorders,Eye,N
14,2,Metamorphopsia,Visual disorders NEC,Vision disorders,Eye,N
14,3,Night blindness,Visual impairment and blindness (excl colour blindness),Vision disorders,Eye,N
14,4,Vision blurred,Visual disorders NEC,Vision disorders,Eye,N
14,5,Visual impairment,Visual impairment and blindness (excl colour blindness),Vision disorders,Eye,N
15,1,Retinal artery occlusion,Retinal bleeding and vascular disorders (excl retinopathy),"Retina, choroid and vitreous haemorrhages and vascular disorders",Eye,N
15,2,Therapy non-responder,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
16,1,Blindness transient,Visual impairment and blindness (excl colour blindness),Vision disorders,Eye,N
16,2,Retinal artery occlusion,Retinal bleeding and vascular disorders (excl retinopathy),"Retina, choroid and vitreous haemorrhages and vascular disorders",Eye,N
16,3,Therapy non-responder,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
17,1,Retinal haemorrhage,Retinal bleeding and vascular disorders (excl retinopathy),"Retina, choroid and vitreous haemorrhages and vascular disorders",Eye,N
18,1,Retinal tear,"Retinal structural change, deposit and degeneration","Ocular structural change, deposit and degeneration NEC",Eye,N
19,1,Disease progression,General signs and symptoms NEC,General system disorders NEC,Genrl,N
19,2,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
19,3,Macular hole,"Retinal structural change, deposit and degeneration","Ocular structural change, deposit and degeneration NEC",Eye,N
20,1,Disease progression,General signs and symptoms NEC,General system disorders NEC,Genrl,N
20,2,Macular hole,"Retinal structural change, deposit and degeneration","Ocular structural change, deposit and degeneration NEC",Eye,N
21,1,Disease progression,General signs and symptoms NEC,General system disorders NEC,Genrl,N
21,2,Macular hole,"Retinal structural change, deposit and degeneration","Ocular structural change, deposit and degeneration NEC",Eye,N
22,1,Disease progression,General signs and symptoms NEC,General system disorders NEC,Genrl,N
22,2,Macular hole,"Retinal structural change, deposit and degeneration","Ocular structural change, deposit and degeneration NEC",Eye,N
23,1,Disease progression,General signs and symptoms NEC,General system disorders NEC,Genrl,N
23,2,Macular hole,"Retinal structural change, deposit and degeneration","Ocular structural change, deposit and degeneration NEC",Eye,N
24,1,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
24,2,Visual acuity reduced,Visual impairment and blindness (excl colour blindness),Vision disorders,Eye,N
25,1,Disease progression,General signs and symptoms NEC,General system disorders NEC,Genrl,N
25,2,Dyschromatopsia,Colour blindness (incl acquired),Vision disorders,Eye,N
25,3,Macular hole,"Retinal structural change, deposit and degeneration","Ocular structural change, deposit and degeneration NEC",Eye,N
25,4,Metamorphopsia,Visual disorders NEC,Vision disorders,Eye,N
25,5,Photopsia,Visual disorders NEC,Vision disorders,Eye,N
25,6,Vision blurred,Visual disorders NEC,Vision disorders,Eye,N
25,7,Visual acuity reduced,Visual impairment and blindness (excl colour blindness),Vision disorders,Eye,N
25,8,Visual impairment,Visual impairment and blindness (excl colour blindness),Vision disorders,Eye,N
25,9,Vitreous floaters,"Choroid and vitreous structural change, deposit and degeneration","Ocular structural change, deposit and degeneration NEC",Eye,N
26,1,Disease progression,General signs and symptoms NEC,General system disorders NEC,Genrl,N
26,2,Macular hole,"Retinal structural change, deposit and degeneration","Ocular structural change, deposit and degeneration NEC",Eye,N
27,1,Disease progression,General signs and symptoms NEC,General system disorders NEC,Genrl,N
27,2,Macular hole,"Retinal structural change, deposit and degeneration","Ocular structural change, deposit and degeneration NEC",Eye,N
27,3,Subretinal fluid,"Retinal structural change, deposit and degeneration","Ocular structural change, deposit and degeneration NEC",Eye,N
27,4,Visual acuity reduced,Visual impairment and blindness (excl colour blindness),Vision disorders,Eye,N
28,1,Macular hole,"Retinal structural change, deposit and degeneration","Ocular structural change, deposit and degeneration NEC",Eye,N
29,1,Macular hole,"Retinal structural change, deposit and degeneration","Ocular structural change, deposit and degeneration NEC",Eye,N
29,2,Photopsia,Visual disorders NEC,Vision disorders,Eye,N
29,3,Subretinal fluid,"Retinal structural change, deposit and degeneration","Ocular structural change, deposit and degeneration NEC",Eye,N
29,4,Visual acuity reduced,Visual impairment and blindness (excl colour blindness),Vision disorders,Eye,N
30,1,Colour blindness,Ocular disorders congenital NEC,Eye disorders congenital,Cong,N
30,2,Disease progression,General signs and symptoms NEC,General system disorders NEC,Genrl,N
30,3,Macular hole,"Retinal structural change, deposit and degeneration","Ocular structural change, deposit and degeneration NEC",Eye,N
30,4,Night blindness,Visual impairment and blindness (excl colour blindness),Vision disorders,Eye,N
30,5,Retinal artery occlusion,Retinal bleeding and vascular disorders (excl retinopathy),"Retina, choroid and vitreous haemorrhages and vascular disorders",Eye,N
30,6,Retinogram abnormal,Ophthalmic histopathology and imaging procedures,"Neurological, special senses and psychiatric investigations",Inv,N
30,7,Visual acuity reduced,Visual impairment and blindness (excl colour blindness),Vision disorders,Eye,N
31,1,Disease progression,General signs and symptoms NEC,General system disorders NEC,Genrl,N
31,2,Dyschromatopsia,Colour blindness (incl acquired),Vision disorders,Eye,N
31,3,Macular hole,"Retinal structural change, deposit and degeneration","Ocular structural change, deposit and degeneration NEC",Eye,N
32,1,Retinal detachment,"Retinal structural change, deposit and degeneration","Ocular structural change, deposit and degeneration NEC",Eye,N
33,1,Macular hole,"Retinal structural change, deposit and degeneration","Ocular structural change, deposit and degeneration NEC",Eye,N
33,2,Retinal tear,"Retinal structural change, deposit and degeneration","Ocular structural change, deposit and degeneration NEC",Eye,N
33,3,Rhegmatogenous retinal detachment,"Retinal structural change, deposit and degeneration","Ocular structural change, deposit and degeneration NEC",Eye,N
33,4,Visual acuity reduced,Visual impairment and blindness (excl colour blindness),Vision disorders,Eye,N
34,1,Macular hole,"Retinal structural change, deposit and degeneration","Ocular structural change, deposit and degeneration NEC",Eye,N
35,1,Macular hole,"Retinal structural change, deposit and degeneration","Ocular structural change, deposit and degeneration NEC",Eye,N
36,1,Retinal detachment,"Retinal structural change, deposit and degeneration","Ocular structural change, deposit and degeneration NEC",Eye,N
37,1,Retinal detachment,"Retinal structural change, deposit and degeneration","Ocular structural change, deposit and degeneration NEC",Eye,N
38,1,Visual acuity reduced,Visual impairment and blindness (excl colour blindness),Vision disorders,Eye,N
39,1,Visual acuity reduced,Visual impairment and blindness (excl colour blindness),Vision disorders,Eye,N
40,1,Product preparation issue,Product preparation errors and issues,Medication errors and other product use errors and issues,Inj&P,N
40,2,Retinal detachment,"Retinal structural change, deposit and degeneration","Ocular structural change, deposit and degeneration NEC",Eye,N
40,3,Retinal tear,"Retinal structural change, deposit and degeneration","Ocular structural change, deposit and degeneration NEC",Eye,N
40,4,Visual field defect,Visual field disorders,Vision disorders,Eye,N
41,1,Macular hole,"Retinal structural change, deposit and degeneration","Ocular structural change, deposit and degeneration NEC",Eye,N
42,1,Detachment of retinal pigment epithelium,"Retinal structural change, deposit and degeneration","Ocular structural change, deposit and degeneration NEC",Eye,N
42,2,Retinal injury,Eye injuries NEC,Injuries NEC,Inj&P,N
42,3,Subretinal fluid,"Retinal structural change, deposit and degeneration","Ocular structural change, deposit and degeneration NEC",Eye,N
42,4,Visual acuity reduced,Visual impairment and blindness (excl colour blindness),Vision disorders,Eye,N
42,5,Visual impairment,Visual impairment and blindness (excl colour blindness),Vision disorders,Eye,N
43,1,Retinal detachment,"Retinal structural change, deposit and degeneration","Ocular structural change, deposit and degeneration NEC",Eye,N
44,1,Retinal injury,Eye injuries NEC,Injuries NEC,Inj&P,N
44,2,Visual acuity reduced,Visual impairment and blindness (excl colour blindness),Vision disorders,Eye,N
45,1,Retinal injury,Eye injuries NEC,Injuries NEC,Inj&P,N
45,2,Visual acuity reduced,Visual impairment and blindness (excl colour blindness),Vision disorders,Eye,N
46,1,Retinal injury,Eye injuries NEC,Injuries NEC,Inj&P,N
46,2,Visual acuity reduced,Visual impairment and blindness (excl colour blindness),Vision disorders,Eye,N
47,1,Disease progression,General signs and symptoms NEC,General system disorders NEC,Genrl,N
47,2,Macular hole,"Retinal structural change, deposit and degeneration","Ocular structural change, deposit and degeneration NEC",Eye,N
47,3,Visual acuity reduced,Visual impairment and blindness (excl colour blindness),Vision disorders,Eye,N
48,1,Retinal tear,"Retinal structural change, deposit and degeneration","Ocular structural change, deposit and degeneration NEC",Eye,N
49,1,Cerebrovascular accident,Central nervous system haemorrhages and cerebrovascular accidents,Central nervous system vascular disorders,Nerv,N
49,2,Therapy non-responder,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
50,1,Drug ineffective for unapproved indication,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
50,2,Eye haemorrhage,Ocular bleeding and vascular disorders NEC,Ocular haemorrhages and vascular disorders NEC,Eye,N
50,3,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
51,1,Disease progression,General signs and symptoms NEC,General system disorders NEC,Genrl,N
51,2,Dyschromatopsia,Colour blindness (incl acquired),Vision disorders,Eye,N
51,3,Macular hole,"Retinal structural change, deposit and degeneration","Ocular structural change, deposit and degeneration NEC",Eye,N
51,4,Photopsia,Visual disorders NEC,Vision disorders,Eye,N
51,5,Retinal injury,Eye injuries NEC,Injuries NEC,Inj&P,N
51,6,Visual acuity reduced,Visual impairment and blindness (excl colour blindness),Vision disorders,Eye,N
51,7,Visual impairment,Visual impairment and blindness (excl colour blindness),Vision disorders,Eye,N
52,1,Disease progression,General signs and symptoms NEC,General system disorders NEC,Genrl,N
52,2,Drug ineffective for unapproved indication,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
52,3,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
52,4,Retinal disorder,Ocular disorders NEC,Eye disorders NEC,Eye,N
52,5,Visual acuity reduced,Visual impairment and blindness (excl colour blindness),Vision disorders,Eye,N
53,1,Disease progression,General signs and symptoms NEC,General system disorders NEC,Genrl,N
53,2,Macular hole,"Retinal structural change, deposit and degeneration","Ocular structural change, deposit and degeneration NEC",Eye,N
53,3,Photopsia,Visual disorders NEC,Vision disorders,Eye,N
53,4,Visual acuity reduced,Visual impairment and blindness (excl colour blindness),Vision disorders,Eye,N
54,1,Disease progression,General signs and symptoms NEC,General system disorders NEC,Genrl,N
54,2,Macular hole,"Retinal structural change, deposit and degeneration","Ocular structural change, deposit and degeneration NEC",Eye,N
54,3,Surgical failure,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
55,1,Disease progression,General signs and symptoms NEC,General system disorders NEC,Genrl,N
55,2,Macular hole,"Retinal structural change, deposit and degeneration","Ocular structural change, deposit and degeneration NEC",Eye,N
56,1,Photopsia,Visual disorders NEC,Vision disorders,Eye,N
56,2,Retinal injury,Eye injuries NEC,Injuries NEC,Inj&P,N
56,3,Retinal toxicity,"Retinal structural change, deposit and degeneration","Ocular structural change, deposit and degeneration NEC",Eye,N
56,4,Therapy non-responder,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
56,5,Visual acuity reduced,Visual impairment and blindness (excl colour blindness),Vision disorders,Eye,N
57,1,Cataract,Cataract conditions,"Anterior eye structural change, deposit and degeneration",Eye,N
57,2,Disease progression,General signs and symptoms NEC,General system disorders NEC,Genrl,N
57,3,Dyschromatopsia,Colour blindness (incl acquired),Vision disorders,Eye,N
57,4,Foreign body sensation in eyes,Ocular sensation disorders,Ocular sensory symptoms NEC,Eye,N
57,5,Macular hole,"Retinal structural change, deposit and degeneration","Ocular structural change, deposit and degeneration NEC",Eye,N
57,6,Miosis,Pupil disorders,Ocular neuromuscular disorders,Eye,N
57,7,Ocular discomfort,Ocular disorders NEC,Eye disorders NEC,Eye,N
57,8,Photophobia,Ocular sensation disorders,Ocular sensory symptoms NEC,Eye,N
57,9,Photopsia,Visual disorders NEC,Vision disorders,Eye,N
57,10,Vision blurred,Visual disorders NEC,Vision disorders,Eye,N
57,11,Visual field defect,Visual field disorders,Vision disorders,Eye,N
57,12,Visual field defect,Visual field disorders,Vision disorders,Eye,N
57,13,Visual impairment,Visual impairment and blindness (excl colour blindness),Vision disorders,Eye,N
57,14,Vitreous floaters,"Choroid and vitreous structural change, deposit and degeneration","Ocular structural change, deposit and degeneration NEC",Eye,N
58,1,Retinal detachment,"Retinal structural change, deposit and degeneration","Ocular structural change, deposit and degeneration NEC",Eye,N
58,2,Retinal tear,"Retinal structural change, deposit and degeneration","Ocular structural change, deposit and degeneration NEC",Eye,N
59,1,Pupillary reflex impaired,Pupil disorders,Ocular neuromuscular disorders,Eye,N
59,2,Retinogram abnormal,Ophthalmic histopathology and imaging procedures,"Neurological, special senses and psychiatric investigations",Inv,N
59,3,Vision blurred,Visual disorders NEC,Vision disorders,Eye,N
59,4,Visual acuity reduced,Visual impairment and blindness (excl colour blindness),Vision disorders,Eye,N
59,5,Visual impairment,Visual impairment and blindness (excl colour blindness),Vision disorders,Eye,N
60,1,Macular hole,"Retinal structural change, deposit and degeneration","Ocular structural change, deposit and degeneration NEC",Eye,N
61,1,Visual acuity reduced,Visual impairment and blindness (excl colour blindness),Vision disorders,Eye,N
62,1,Dyschromatopsia,Colour blindness (incl acquired),Vision disorders,Eye,N
62,2,Visual acuity reduced,Visual impairment and blindness (excl colour blindness),Vision disorders,Eye,N
63,1,Ciliary zonular dehiscence,"Iris and ciliary body structural change, deposit and degeneration","Anterior eye structural change, deposit and degeneration",Eye,N
63,2,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
64,1,Ciliary zonular dehiscence,"Iris and ciliary body structural change, deposit and degeneration","Anterior eye structural change, deposit and degeneration",Eye,N
64,2,Disease progression,General signs and symptoms NEC,General system disorders NEC,Genrl,N
64,3,Macular hole,"Retinal structural change, deposit and degeneration","Ocular structural change, deposit and degeneration NEC",Eye,N
64,4,Photophobia,Ocular sensation disorders,Ocular sensory symptoms NEC,Eye,N
64,5,Photopsia,Visual disorders NEC,Vision disorders,Eye,N
64,6,Retinogram abnormal,Ophthalmic histopathology and imaging procedures,"Neurological, special senses and psychiatric investigations",Inv,N
64,7,Visual acuity reduced,Visual impairment and blindness (excl colour blindness),Vision disorders,Eye,N
65,1,Lens dislocation,"Lens structural change, deposit and degeneration (excl cataracts)","Anterior eye structural change, deposit and degeneration",Eye,N
65,2,Lenticular injury,Eye injuries NEC,Injuries NEC,Inj&P,N
66,1,Drug ineffective for unapproved indication,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
66,2,Lens dislocation,"Lens structural change, deposit and degeneration (excl cataracts)","Anterior eye structural change, deposit and degeneration",Eye,N
67,1,Macular detachment,"Retinal structural change, deposit and degeneration","Ocular structural change, deposit and degeneration NEC",Eye,N
67,2,Retinal injury,Eye injuries NEC,Injuries NEC,Inj&P,N
67,3,Subretinal fluid,"Retinal structural change, deposit and degeneration","Ocular structural change, deposit and degeneration NEC",Eye,N
67,4,Visual acuity reduced,Visual impairment and blindness (excl colour blindness),Vision disorders,Eye,N
68,1,Blindness unilateral,Visual impairment and blindness (excl colour blindness),Vision disorders,Eye,N
68,2,Macular hole,"Retinal structural change, deposit and degeneration","Ocular structural change, deposit and degeneration NEC",Eye,N
68,3,Photopsia,Visual disorders NEC,Vision disorders,Eye,N
68,4,Visual impairment,Visual impairment and blindness (excl colour blindness),Vision disorders,Eye,N
69,1,Disease recurrence,General signs and symptoms NEC,General system disorders NEC,Genrl,N
69,2,Disease recurrence,General signs and symptoms NEC,General system disorders NEC,Genrl,N
69,3,Macular hole,"Retinal structural change, deposit and degeneration","Ocular structural change, deposit and degeneration NEC",Eye,N
69,4,Macular hole,"Retinal structural change, deposit and degeneration","Ocular structural change, deposit and degeneration NEC",Eye,N
69,5,Ocular hyperaemia,"Ocular infections, inflammations and associated manifestations","Ocular infections, irritations and inflammations",Eye,N
69,6,Photophobia,Ocular sensation disorders,Ocular sensory symptoms NEC,Eye,N
69,7,Photopsia,Visual disorders NEC,Vision disorders,Eye,N
69,8,Retinal injury,Eye injuries NEC,Injuries NEC,Inj&P,N
69,9,Subretinal fluid,"Retinal structural change, deposit and degeneration","Ocular structural change, deposit and degeneration NEC",Eye,N
69,10,Vision blurred,Visual disorders NEC,Vision disorders,Eye,N
69,11,Visual impairment,Visual impairment and blindness (excl colour blindness),Vision disorders,Eye,N
69,12,Visual impairment,Visual impairment and blindness (excl colour blindness),Vision disorders,Eye,N
69,13,Visual impairment,Visual impairment and blindness (excl colour blindness),Vision disorders,Eye,N
69,14,Visual impairment,Visual impairment and blindness (excl colour blindness),Vision disorders,Eye,N
69,15,Vitreous floaters,"Choroid and vitreous structural change, deposit and degeneration","Ocular structural change, deposit and degeneration NEC",Eye,N
70,1,Macular hole,"Retinal structural change, deposit and degeneration","Ocular structural change, deposit and degeneration NEC",Eye,N
71,1,Visual impairment,Visual impairment and blindness (excl colour blindness),Vision disorders,Eye,N
72,1,Macular hole,"Retinal structural change, deposit and degeneration","Ocular structural change, deposit and degeneration NEC",Eye,N
73,1,Macular detachment,"Retinal structural change, deposit and degeneration","Ocular structural change, deposit and degeneration NEC",Eye,N
73,2,Subretinal fluid,"Retinal structural change, deposit and degeneration","Ocular structural change, deposit and degeneration NEC",Eye,N
74,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
